SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001047469-16-016293
Filing Date
2016-10-26
Accepted
2016-10-26 08:24:14
Documents
11

Document Format Files

Seq Description Document Type Size
1 424B4 a2230046z424b4.htm 424B4 2384073
2 G448348.JPG g448348.jpg GRAPHIC 8102
3 G197906.JPG g197906.jpg GRAPHIC 102254
4 G792843.JPG g792843.jpg GRAPHIC 33249
5 G726419.JPG g726419.jpg GRAPHIC 63319
6 G259267.JPG g259267.jpg GRAPHIC 69714
7 G281423.JPG g281423.jpg GRAPHIC 46051
8 G685331.JPG g685331.jpg GRAPHIC 63796
9 G1017555.JPG g1017555.jpg GRAPHIC 48011
10 G734436.JPG g734436.jpg GRAPHIC 89738
11 G26724.JPG g26724.jpg GRAPHIC 2004
  Complete submission text file 0001047469-16-016293.txt   3111320
Mailing Address ONE KENDALL SQUARE SUITE B14301 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B14301 CAMBRIDGE MA 02139 (617) 401-4060
Ra Pharmaceuticals, Inc. (Filer) CIK: 0001481512 (see all company filings)

IRS No.: 262908274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-213917 | Film No.: 161951587
SIC: 2834 Pharmaceutical Preparations